Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review
| Author | Abhishek Singh | en |
| Author | Basavaraj Ankalagi | en |
| Author | Puneet Khanna | en |
| Issued Date | 2021-12-31 | en |
| Abstract | Severe COVID-19 disease is currently being managed with glucocorticoids. As a result, there are increasing reports of COVID-19 associated mucormycosis. (CAM) Patients with diabetes mellitus, organ transplant recipients, and in immune-compromised patients either due to cancer chemotherapy or with HIV and AIDS are at high risk of developing CAM. Pharmacotherapy with antifungal agents like Amphotericin B and surgery are the main treatment options. In this narrative review, we will discuss the challenges and anesthetic concern while managing CAM. | en |
| DOI | https://doi.org/10.22037/jcma.v6i4.35302 | en |
| Keyword | COVID-19 associated mucormycosis | en |
| Keyword | Airway | en |
| Keyword | Anesthetic concerns | en |
| Publisher | Brieflands | en |
| Title | Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review | en |
| Type | Review | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 165729.pdf
- Size:
- 373.79 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF